These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions. Schmitt D, Thivolet J. J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276 [Abstract] [Full Text] [Related]
14. Combined immunological and histochemical analysis of skin and lymph node lesions in histiocytosis X. Thomas JA, Janossy G, Chilosi M, Pritchard J, Pincott JR. J Clin Pathol; 1982 Mar; 35(3):327-37. PubMed ID: 6175664 [Abstract] [Full Text] [Related]
19. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study. Harrist TJ, Muhlbauer JE, Murphy GF, Mihm MC, Bhan AK. J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218 [Abstract] [Full Text] [Related]
20. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Lau SK, Chu PG, Weiss LM. Am J Surg Pathol; 2008 Apr; 32(4):615-9. PubMed ID: 18277880 [Abstract] [Full Text] [Related] Page: [Next] [New Search]